US Stock MarketDetailed Quotes
JANX Janux Therapeutics
- 50.310
- +3.810+8.19%
Close Nov 22 16:00 ET
- 50.750
- +0.440+0.87%
Post 20:01 ET
2.64BMarket Cap-43000P/E (TTM)
50.630High46.020Low797.81KVolume46.500Open46.500Pre Close38.71MTurnover2.10%Turnover RatioLossP/E (Static)52.48MShares65.60052wk High4.02P/B1.91BFloat Cap7.79052wk Low--Dividend TTM38.01MShs Float65.600Historical High--Div YieldTTM9.91%Amplitude5.650Historical Low48.525Avg Price1Lot Size
Janux Therapeutics Key Stats
EPS
According to the latest financial report of Janux Therapeutics, the latest earnings per share (TTM) for the company is -0.51. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Janux Therapeutics's free cash flow? The latest report shows it as -2.26M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Janux Therapeutics shows that the company's current ratio is 38.80, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Janux Therapeutics, the quick ratio is 38.58, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Janux Therapeutics? The latest ROE figure is -4.27%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Janux Therapeutics, the total asset return on investment (ROA) is -4.05%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Janux Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Janux Therapeutics, the net profit margin is -6.39K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data